Cadonilimab Combined With CapeOX Regimen in Perioperative Treatment of Resectable Locally Advanced Gastric Cancer

Condition:   Locally Advanced Unresectable Gastric Adenocarcinoma Interventions:   Drug: Oxaliplatin;   Drug: Capecitabine;   Drug: Cadonilimab Sponsor:   Tianjin Medical University Cancer Institute and Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials